Newsfeeds - Spark Newswire

3 minute read

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

Today, 7:17 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26)

AGEN

5 minute read

63 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:17 AM

Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume.

ABVC

1 minute read

BeyondSpring Inks Plinabulin Agreement In Greater China

By Vandana Singh

Today, 7:17 AM

BeyondSpring Inc (NASDAQ:BYSI) and Jiangsu Hengrui Pharmaceuticals Co Ltd have entered into an exclusive commercialization and co-development agreement for plinabulin in Greater China.…

BYSI

5 minute read

The Daily Biotech Pulse: Early Approval For Ascendis’ Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO

By Shanthi Rexaline

Today, 7:17 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25)

ABBV

5 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:17 AM

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.

ABVC

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 7:17 AM

ALIM

3 minute read

35 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 7:17 AM

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.

ALXO

6 minute read

84 Biggest Movers From Friday

By Lisa Levin

Today, 7:17 AM

Gainers

ACOR

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 7:17 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

1 minute read

Why BeyondSpring’s Stock Is Soaring Higher

By Henry Khederian

Today, 7:17 AM

BeyondSpring Inc (NASDAQ: BYSI) shares are trading higher by 22.5% at $26.59 Friday afternoon on continued strength after the company earlier in the week announced results from its DUBLIN-3 trial of plinabulin in combination with docetaxel, which met its primary endpoint.

BYSI